Cancer Genomics Research

About Arima Genomics

Arima Genomics, founded in 2015 and based in San Diego, is a leader in 3D genomics, commercializing a robust Hi-C technology platform. The company operates a dual business model, providing research tools and services while also offering a CLIA-certified clinical diagnostic test (Aventa) for detecting gene fusions and rearrangements in cancer. With a recent $22 million Series C financing and partnerships with companies like Velsera, Arima is positioned to expand the adoption of its structural genomics approach in both research and clinical markets.

Therapeutic Areas